Searched for
SUN PHARMA ORGANON DEAL ANALYSIS
India's current account deficit to remain 1.5-1.7% of GDP in FY27 but RBI measures may turn BoP surplus: SBI Report- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, Vedanta
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...09 Jun, 2026, 07.34 PM IST
- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....09 Jun, 2026, 03.15 PM IST
- Cost benefit in the long run: India needs right energy, at the right place and at the right timeCritics question the market viability of Small Modular Reactors (SMRs) due to high costs compared to renewable energy. However, a full syst...08 Jun, 2026, 11.44 PM IST
- Q4 FY26 earnings: Metal companies lead growth, backed by robust volumes and favourable pricing trendsET Wealth presents an 8-quarter earnings assessment report of various sectors. The year-on-year net profit growth for 18 sectors is present...08 Jun, 2026, 11.30 AM IST
- Switzerland just buried solar panels under a live train track to get clean energyA Swiss startup, Sun-Ways, has installed solar panels between railway tracks in western Switzerland. This innovative project tests if train...05 Jun, 2026, 04.24 PM IST
- Go Digit Insurance shares jump 9% after Rs 100 crore block deal attracts MFs, global investorGo Digit General Insurance shares saw a significant jump. This surge followed a Rs 100-crore block deal. Aditya Birla Sun Life Mutual Fund ...05 Jun, 2026, 11.15 AM IST
- Stocks in news: Rajesh Exports, Lenskart, Suzlon Energy, Aurobindo Pharma, Tata MotorsIndian markets saw volatility and closed lower on Wednesday. Key companies are in focus due to significant developments. SoftBank reduced i...04 Jun, 2026, 06.43 AM IST
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...02 Jun, 2026, 03.30 PM IST
- Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...02 Jun, 2026, 12.05 AM IST
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...31 May, 2026, 01.34 PM IST
- Buy, Sell or Hold: Citi maintains buy on Eicher Motors; Goldman Sachs retains buy on Max HealthcareBrokerages maintain a positive outlook on select large-cap pharmaceutical, automobile, and healthcare stocks, citing strong growth prospect...25 May, 2026, 09.56 AM IST
- Margin pressure, slower growth outlook may cap upside for Sun Pharma stockSun Pharma reported strong revenue and profit growth in the March quarter, but EBITDA margins faced pressure from increased investments and...25 May, 2026, 06.15 AM IST
- Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration dealSun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales by FY2027. ...23 May, 2026, 01.04 AM IST
- Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividendSun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while re...22 May, 2026, 03.13 PM IST
- Citi sees India IPOs hitting fresh records despite challengesIndian initial public offerings are poised for a strong comeback in the latter half of the year. Citigroup anticipates deal volumes to meet...21 May, 2026, 12.28 PM IST
- Stock Radar: Sun Pharma breaks out from falling trendline resistance to hit fresh 52-week high; time to buy?Sun Pharmaceutical Industries Ltd has broken out from a falling trendline resistance on weekly charts, hitting a fresh 52-week high. Expert...18 May, 2026, 05.00 AM IST
- Sun Pharma explores funding mix for $12 billion Organon dealGlobal lenders are exploring various financing options for Sun Pharmaceutical Industries' proposed $12 billion acquisition of Organon & Co....06 May, 2026, 06.53 AM IST
Load More
